Journal of Eating Disorders - The Consciousness Library

Acute response and neurophysiological mechanisms of mindfulness meditation in emotional eating.

Journal of Eating Disorders March 31, 2026 Roy Rongyue Zeng, Rangchun Hou, Hiu Yin Lai et al.

Emotional eating often leads to adverse health outcomes. Understanding how mindfulness influences emotional eating is crucial for developing strategies to promote healthier eating behaviors and well-being. This study aims to investigate the mechanism and acute response to a mindfulness meditation practice on emotional eating by examining immediate post-intervention effects on brain activity and...

DOI: 10.1186/s40337-026-01591-0 Full text Mindfulness Disordered eating behavior Electroencephalography Emotional regulation +2

Rebuttal to “Questioning the recovery of dissociated traumatic memories under psilocybin”

Journal of Eating Disorders February 17, 2026 Stéphanie Knatz Peck, Timothy D Brewerton

In our original case report we provide detailed accounts of two research participants who reported the emergence of spontaneously recovered, previously forgotten traumatic memories of sexual assaults during psilocybin treatment. In their commentary of this article, Kangaslampi et al. argue that we preemptively label the experiences as dissociated traumatic memories in the absence of...

DOI: 10.1186/s40337-026-01532-x Full text Rebuttal Traumatic memories Hypnosis Psychotherapist +4

An open-label pilot study of psilocybin-assisted therapy for binge eating disorder.

Journal of Eating Disorders January 3, 2026 Jesse Dallery, Jennifer L Miller, Jeff Boissoneault et al. 1 citation

Binge Eating Disorder (BED) is the most prevalent eating disorder and is associated with psychiatric comorbidities, health impairments, and decreased quality of life. Emerging evidence suggests that psilocybin-assisted therapy may promote cognitive and emotional flexibility and disrupt maladaptive behavioral patterns, making it a promising candidate for BED treatment. This open-label pilot...

DOI: 10.1186/s40337-025-01508-3 Full text Psilocybin Binge-eating disorder Neuroimaging

Exploring MDMA assisted therapy in eating disorders: mechanisms, clinical evidence, and future directions.

Journal of Eating Disorders December 29, 2025 Michael Harkhoe, Tim Offringa, Eric Vermetten

Patients with eating disorders (EDs), particularly anorexia nervosa (AN), experience a complex psychiatric condition often characterized by extreme food restriction, intense fear of weight gain, elevated levels of emotional dysregulation, body image disturbance, and comorbid trauma. Several of these factors can undermine the therapeutic alliance and reduce engagement with treatment,...

DOI: 10.1186/s40337-025-01409-5 Full text PTSD Anorexia nervosa Eating disorders MDMA-Assisted Therapy

Ketamine for treatment resistant depression in individuals with eating disorders: a comparison study

Journal of Eating Disorders December 9, 2025 Elizabeth Wassenaar, Dan V. Blalock, Alan Duffy et al. 1 citation

Individuals with eating disorders (EDs) have an increased risk of treatment resistant depression (TRD) and treatment resistant bipolar disorder (TRBD) and a higher rate of suicidal ideation and death by suicide than individuals without EDs. Individuals with EDs are less responsive to conventional treatments for mood disorders than individuals without EDs. Ketamine has evidence for treatment of...

DOI: 10.1186/s40337-025-01448-y Full text Ketamine Treatment-resistant depression Depression economics Population +2

Questioning the recovery of dissociated traumatic memories under psilocybin: comment on “Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa”

Journal of Eating Disorders December 4, 2025 Samuli Kangaslampi, Max Wolff, Manoj K. Doss et al. 1 citation

Abstract In their recent case report article, Peck and colleagues suggested that two patients recovered dissociated traumatic memories during psilocybin treatment for anorexia nervosa. These case reports are of clinical and scientific interest and confirm that psychedelics may induce vivid memory-like experiences. However, the reports warrant scrutiny. Here, based on what is known about...

DOI: 10.1186/s40337-025-01484-8 Full text Psilocybin Traumatic memories Anorexia Dissociative +7

Psychedelic use in individuals living with eating disorders or disordered eating: findings from the international MED-FED survey.

Journal of Eating Disorders July 24, 2025 Sarah-Catherine Rodan, Noah Meez, Sophie Lloyd-Hurwitz et al. 2 citations

There are few effective treatments for eating disorders (EDs), and new interventions are urgently needed. The MEDication and other drugs For Eating Disorders ("MED-FED") survey investigated the lived experience of adults with EDs regarding their prescription and non-prescription drugs use. Psychedelic drugs were highly rated in this survey for their impact on ED symptoms and general mental...

DOI: 10.1186/s40337-025-01328-5 Full text DMT LSD Magic mushrooms Psilocybin +7

Reconnecting through dissociation: a 5-month follow-up case study on ketamine-assisted psychotherapy for anorexia nervosa.

Journal of Eating Disorders June 10, 2025 Camilla Lindvall Dahlgren, Elisabeth Tverrli, Lowan Han Stewart 3 citations

Ketamine, an N-methyl-D-aspartate receptor antagonist, has demonstrated rapid antidepressant effects at sub-anesthetic doses, making it a promising candidate for treatment-resistant mood disorders, anxiety, post-traumatic stress disorder, suicidality, and recently, eating disorders (EDs). However, its effects are transient, and ketamine-assisted psychotherapy (KAP) has emerged as a method to...

DOI: 10.1186/s40337-025-01313-y Full text Case report Dissociation Follow-up Ketamine-assisted psychotherapy +5

Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa

Journal of Eating Disorders May 26, 2025 Julie Trim, Samantha Shao, Nadav Liam Modlin et al. 14 citations

PT may hold promise not only in the treatment of eating disorders but also trauma-related disorders, including PTSD and dissociative amnesia. Potential mechanisms of psilocybin's facilitation of remembering and processing traumatic material is reviewed.

DOI: 10.1186/s40337-025-01274-2 Psilocybin Anorexia nervosa Psychotherapist Hallucinogen

Mindfulness-based interventions and their relationships with body image and eating behavior in adolescents: a scoping review.

Journal of Eating Disorders May 1, 2025 Silvia Patrícia de Oliveira Silva Bacalhau, Luciana Gonçalves de Orange, Marco Aurélio de Valois Correia Junior et al. 9 citations

During adolescence, there are risks of changes in eating behavior and concerns about weight and body shape. Mindfulness-based interventions (MBIs) may bring benefits to this population. This study aimed to assess research that carried out MBIs and its repercussions onbody image and eating behavior in non-clinical adolescents. This is a scoping review study that followed the JBI methodology and...

DOI: 10.1186/s40337-025-01238-6 Full text Body image Feeding behavior Mindful eating Mindfulness-based interventions +3

The compulsive eating paradigm: can psychedelics help in treating obesity?

Journal of Eating Disorders April 7, 2025 Dhanush Ammineni, Rebecca J. Park 1 citation

Obesity is a multifactorial disorder involving a behavioural aetiology in subsets of patients that traditional therapeutic approaches have failed to address. Drawing parallels with addiction, the rewarding aspects of a chronic energy-dense diet can compromise dopaminergic reward circuits, eventually causing individuals to become habitually responsive to food-related stimuli despite adverse...

DOI: 10.1186/s40337-024-01186-7 Full text Eating disorders Psychedelics Addiction treatment Obesity therapy

Ketamine as adjuvant treatment in eating disorders: an exploratory study of a case series and retrospective analysis.

Journal of Eating Disorders March 17, 2025 Paula J Escobedo-Aedo, Chris Serrand, Sarah Kabani et al. 4 citations

Eating disorders (EDs) significantly impair physical health and psychosocial functioning. Few effective therapeutic approaches exist for EDs, particularly in Anorexia Nervosa (AN). The use of ketamine, already characterized as a noncompetitive NMDA antagonist anesthetic in depression and suicidal ideations, could be an innovative adjuvant treatment for the AN spectrum. We describe a case series...

DOI: 10.1186/s40337-025-01232-y Full text Ketamine therapy Eating disorder treatment Mental health research Anorexia treatment +5

Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design

Journal of Eating Disorders December 27, 2024 Elena Koning, Cristiano Chaves, Elisa Brietzke et al. 2 citations

Eating disorders (EDs) are a group of debilitating mental illnesses characterized by maladaptive eating behaviors and severe cognitive-emotional dysfunction, directly affecting 1-3% of the population. Standard treatments are not effective in approximately one third of ED cases, representing the need for scientific advancement. There is emerging evidence for the safety and efficacy of...

DOI: 10.1186/s40337-024-01185-8 Psilocybin Anxiety Eating disorders Neuroimaging +11

Beyond the numbers: reimagining healing with psychedelics for eating disorders.

Journal of Eating Disorders September 30, 2024 Adele Lafrance, Meg J. Spriggs, Natalie Gukasyan et al. 8 citations

Psychedelic medicine is currently being evaluated for numerous mental health indications, and there is significant interest in applying these models of care to eating disorders (EDs) given the limited efficacy of available treatment models, especially for those living with anorexia nervosa. Preliminary findings across a number of studies suggest promise. In this commentary, researchers with...

DOI: 10.1186/s40337-024-01111-y Full text Psychedelic therapy Mental health treatment Psilocybin research Anorexia nervosa +3

Improvement in depressive symptoms in a patient with severe and enduring anorexia nervosa and comorbid major depressive disorder using psychotherapy-assisted IV ketamine : a case report.

Journal of Eating Disorders June 12, 2024 Amanda Timek, Catherine Daniels-Brady, Stephen Ferrando 8 citations

Anorexia nervosa is a life-threatening psychiatric illness with a high mortality rate and limited treatment options. This illness is frequently comorbid with major depressive disorder, leading to additional obstacles in patient quality of life, and increasing the mortality rate further due to risk of suicide. Ketamine, a competitive N-methyl-D-aspartate receptor antagonist, has been shown to be...

DOI: 10.1186/s40337-024-01039-3 Full text Major depressive disorder Treatment-resistant depression Case report Ketamine-assisted psychotherapy +4

Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians.

Journal of Eating Disorders April 24, 2024 Amanda E. Downey, Anita V. Chaphekar, Joshua Woolley et al. 13 citations

Clinical trials using psilocybin therapy to treat anorexia nervosa (AN) are currently underway. The safety and tolerability of psilocybin is of utmost importance in individuals with AN who may present unique medical vulnerabilities. The purpose of this review is to describe how the common physiologic adverse effects of psilocybin may impact medical complications experienced by individuals with...

DOI: 10.1186/s40337-024-01005-z Full text Psilocybin Adverse effects Anorexia nervosa Clinical trial +4

A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders.

Journal of Eating Disorders May 6, 2022 Reid Robison, Adele Lafrance, Madeline Brendle et al.

Depression and anxiety outcome measures, safety/tolerability, patient satisfaction, and ease of implementation of group-based ketamine-assisted psychotherapy (G-KAP) delivered to patients in intensive residential eating disorder (ED) treatment were assessed. This study reports on five participants with a diagnosis of an ED and comorbid mood and anxiety disorders who received weekly...

DOI: 10.1186/s40337-022-00588-9 Full text Anxiety Depression Ketamine Case series +1

Papers